Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amaia Zabala-Letona

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Nature|June 22, 2026
Cancer cells adopt unprecedented strategies to produce a molecule that protects them from iron-dependent deathAmaia Zabala-Letona, Arkaitz Carracedo
Aging|July 24, 2018
Re-evaluating statin activity in cancerLaura Camacho, Amaia Zabala-Letona, Arkaitz Carracedo
Science Advances|January 30, 2018
Oil for the cancer engine: The cross-talk between oncogenic signaling and polyamine metabolismAmaia Arruabarrena-Aristorena, Amaia Zabala-Letona, Arkaitz Carracedo
The Journal of Nutrition|June 2, 2011
CLA-enriched diet containing t10,c12-CLA alters bile acid homeostasis and increases the risk of cholelithiasis in miceAmaia Zabala Letona, Isabelle Niot, Fabienne Laugerette, et al.
Nuclear Medicine and Biology|July 12, 2025
Unravelling the role of L- and D- alanine in prostate cancer: a Positron Emission Tomography study in a genetic mouse modelPilar Castellnou, María Gómez-Martínez, Vanessa Gómez-Vallejo, et al.
Cancers|September 10, 2021
Identification of Androgen Receptor Metabolic Correlome Reveals the Repression of Ceramide Kinase by AndrogensLaura Camacho, Amaia Zabala-Letona, Ana R Cortazar, et al.
Molecular Oncology|November 17, 2025
Transcriptional network analysis of PTEN-protein-deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communicationIvana Rondon-Lorefice, Jose I Lopez, Aitziber Ugalde-Olano, et al.
Molecular Oncology|May 13, 2026
USP29-regulated noncanonical stabilization of the hypoxia-inducible factor-α in aggressive prostate cancerAmelie S Schober, Leire Moreno-Cugnon, Laura Martínez-Pérez, et al.
Cell Death & Disease|July 22, 2025
Correction: The PP2A regulator IER5L supports prostate cancer progressionJana R Crespo, Natalia Martín-Martín, Saioa Garcia-Longarte, et al.
Cell Death & Disease|July 18, 2024
The PP2A regulator IER5L supports prostate cancer progressionJana R Crespo, Natalia Martín-Martín, Saioa Garcia-Longarte, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Nature|June 22, 2026
Cancer cells adopt unprecedented strategies to produce a molecule that protects them from iron-dependent deathAmaia Zabala-Letona, Arkaitz Carracedo
Aging|July 24, 2018
Re-evaluating statin activity in cancerLaura Camacho, Amaia Zabala-Letona, Arkaitz Carracedo
Science Advances|January 30, 2018
Oil for the cancer engine: The cross-talk between oncogenic signaling and polyamine metabolismAmaia Arruabarrena-Aristorena, Amaia Zabala-Letona, Arkaitz Carracedo
The Journal of Nutrition|June 2, 2011
CLA-enriched diet containing t10,c12-CLA alters bile acid homeostasis and increases the risk of cholelithiasis in miceAmaia Zabala Letona, Isabelle Niot, Fabienne Laugerette, et al.
Nuclear Medicine and Biology|July 12, 2025
Unravelling the role of L- and D- alanine in prostate cancer: a Positron Emission Tomography study in a genetic mouse modelPilar Castellnou, María Gómez-Martínez, Vanessa Gómez-Vallejo, et al.
Cancers|September 10, 2021
Identification of Androgen Receptor Metabolic Correlome Reveals the Repression of Ceramide Kinase by AndrogensLaura Camacho, Amaia Zabala-Letona, Ana R Cortazar, et al.
Molecular Oncology|November 17, 2025
Transcriptional network analysis of PTEN-protein-deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communicationIvana Rondon-Lorefice, Jose I Lopez, Aitziber Ugalde-Olano, et al.
Molecular Oncology|May 13, 2026
USP29-regulated noncanonical stabilization of the hypoxia-inducible factor-α in aggressive prostate cancerAmelie S Schober, Leire Moreno-Cugnon, Laura Martínez-Pérez, et al.
Cell Death & Disease|July 22, 2025
Correction: The PP2A regulator IER5L supports prostate cancer progressionJana R Crespo, Natalia Martín-Martín, Saioa Garcia-Longarte, et al.
Cell Death & Disease|July 18, 2024
The PP2A regulator IER5L supports prostate cancer progressionJana R Crespo, Natalia Martín-Martín, Saioa Garcia-Longarte, et al.
Pageof 4